Oxytocin
It has been shown that oxytocin differentially affects males and females. Females who are administered oxytocin are overall faster in responding to socially relevant stimuli than males who received oxytocin. Additionally, after the administration of oxytocin, females show increased amygdala activity in response to threatening scenes; however, males do not show increased amygdala activation. This phenomenon can be explained by looking at the role of gonadal hormones, specifically estrogen, which modulate the enhanced threat processing seen in females. Estrogen has been shown to stimulate the release of oxytocin from the hypothalamus and promote receptor binding in the amygdala.
Social connection
In mammals, oxytocin has been found to be released during childbirth, breastfeeding, sexual stimulation, bonding, and in some cases stress. In 1992, Sue Carter discovered that administering oxytocin to prairie voles would accelerate their monogamous pair-bonding behavior. Oxytocin has also been found to play many roles in the bonding between mother and child. In addition to pair-bonding and motherhood, oxytocin has been found to play a role in prosocial behavior and bonding in humans. Nicknamed the “love drug” or “cuddle chemical,” plasma levels of oxytocin increase following physical affection, and are linked to more trusting and generous social behavior, positively biased social memory, attraction, and anxiety and hormonal responses. Further supporting a nuanced role in adult human bonding, greater circulating oxytocin over a 24-hour period was associated with greater love and perceptions of partner responsiveness and gratitude, however was also linked to perceptions of a relationship being vulnerable and in danger. Thus oxytocin may play a flexible role in relationship maintenance, supporting both the feelings that bring us closer and the distress and instinct to fight for an intimate bond in peril.